ZIOPHARM ONCOLOGY, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 12243
 
 
 
C07D HETEROCYCLIC COMPOUNDS 4158
 
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 3135
 
 
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 367
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9346836 Salts of isophosphoramide mustard and analogs thereof as anti-tumor agentsJul 10, 14May 24, 16[A61K, C07F, C07C]
9340563 Salts of isophosphoramide mustard and analogs thereofNov 06, 13May 17, 16[A61K, C07F, C07D]
9254298 Synthesis and formulations of salts of isophosphoramide mustard and analogs thereofJul 23, 15Feb 09, 16[A61K, C07F]
9145431 Synthesis and formulations of salts of isophosphoramide mustard and analogs thereofJan 29, 14Sep 29, 15[A61K, C07F]
8796329 Method for controlling angiogenesis in animalsSep 28, 07Aug 05, 14[A61K, A01N, C07F]
8334398 Compounds and methods for the treatment of cancerJun 01, 11Dec 18, 12[C07C]
7968738 Compounds and methods for the treatment of cancerJul 28, 06Jun 28, 11[C07C]
7964583 Salts of isophosphoramide mustard and analogs thereof as anti-tumor agentsFeb 20, 07Jun 21, 11[A61K]
6344467 N-substituted indole-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating actionSep 30, 99Feb 05, 02[A61K, C07D, A61P]
6232327 Indolyl-3-glyoxylic acid derivatives having antitumor actionApr 02, 99May 15, 01[A61K, C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0215,005 SYNTHESIS AND FORMULATIONS OF SALTS OF ISOPHOSPHORAMIDE MUSTARD AND ANALOGS THEREOFAbandonedJan 04, 16Jul 28, 16[C07F]
2014/0212,495 NANOPARTICULATE COMPOSITIONS OF TUBULIN INHIBITOR COMPOUNDSAbandonedAug 15, 13Jul 31, 14[A61K, C07D]
2014/0193,519 INDIBULIN THERAPYAbandonedAug 02, 13Jul 10, 14[A61K]
8664201 Synthesis and formulations of salts of isophosphoramide mustard and analogs thereofExpiredJul 30, 09Mar 04, 14[A61K, C07F]
8604007 Salts of isophosphoramide mustard and analogs thereofExpiredApr 04, 08Dec 10, 13[A61K]
2013/0261,082 Combination Therapy With Organic ArsenicalsAbandonedMar 06, 13Oct 03, 13[A61K]
2013/0196,000 COMBINATION THERAPY INCLUDING ISOPHOSPHORAMIDE MUSTARD, ANALOGS, OR SALTS THEREOFAbandonedJan 30, 13Aug 01, 13[A61K]
2013/0084,345 INDIBULIN THERAPYAbandonedNov 20, 12Apr 04, 13[A61K]
2012/0295,861 Combination Therapy With Organic ArsenicalsAbandonedJul 26, 12Nov 22, 12[A61K, A61P]
2012/0219,597 PHARMACEUTICAL FORMULATIONS FOR INDIBULINAbandonedSep 01, 10Aug 30, 12[A61K, A61P]
8252773 Combination therapy with organic arsenicalsExpiredOct 31, 08Aug 28, 12[A61K]
2011/0269,697 ORGANOARSENIC COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCERAbandonedAug 14, 09Nov 03, 11[A61K, C07F, A61P, C07K]
2010/0331,403 COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCERAbandonedDec 12, 08Dec 30, 10[A61K]
7579365 Indolyl-3-glyoxylic acid derivatives having antitumor actionExpiredDec 04, 02Aug 25, 09[A61K, C07D]
7452910 Indolyl-3-glyoxylic acid derivatives having therapeutically valuable propertiesExpiredOct 17, 03Nov 18, 08[A61K]
2008/0241,274 Indibulin therapyAbandonedNov 27, 07Oct 02, 08[A61K, A61P]
2008/0057,124 Indolyl-3-glyoxylic acid derivatives having therapeutically valuable propertiesAbandonedAug 20, 07Mar 06, 08[A61K, A61P]
2008/0027,110 Indolyl-3-glyoxylic acid derivatives having antitumor actionAbandonedAug 20, 07Jan 31, 08[A61K, C07D, A61P]
2006/0280,787 Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereofAbandonedJun 14, 05Dec 14, 06[A61K]
2006/0110,462 Nanoparticulate compositions of tubulin inhibitor compoundsAbandonedNov 03, 05May 25, 06[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.